Journal Article

A diagnostic support system based on pain drawings: binary and k-disease classification of EDS, GBS, FSHD, PROMM, and a control group with Pain2D

Sellin, J., Bender, Tim T. A., Emmert, D., Mücke, M., Grigull, L., Klawonn, F., Szczypien, N., Conrad, R., Link, C., Gass, A.

2023

Overview

Background and objective The diagnosis of rare diseases (RDs) is often challenging due to their rarity, variability and the high number of individual RDs, resulting in a delay in diagnosis with adverse effects for patients and healthcare systems. The development of computer assisted diagnostic decision support systems could help to improve these problems by supporting differential diagnosis and by prompting physicians to initiate the right diagnostic tests. Towards this end, we developed, trained and tested a machine learning model implemented as part of the software called Pain2D to classify four rare diseases (EDS, GBS, FSHD and PROMM), as well as a control group of unspecific chronic pain, from pen-and-paper pain drawings filled in by patients. Methods Pain drawings (PDs) were collected from patients suffering from one of the four RDs, or from unspecific chronic pain. The latter PDs were used as an outgroup in order to test how Pain2D handles more common pain causes. A total of 262 (59 EDS, 29 GBS, 35 FSHD, 89 PROMM, 50 unspecific chronic pain) PDs were collected and used to generate disease specific pain profiles. PDs were then classified by Pain2D in a leave-one-out-cross-validation approach. Results Pain2D was able to classify the four rare diseases with an accuracy of 61–77% with its binary classifier. EDS, GBS and FSHD were classified correctly by the Pain2D k-disease classifier with sensitivities between 63 and 86% and specificities between 81 and 89%. For PROMM, the k-disease classifier achieved a sensitivity of 51% and specificity of 90%. Conclusions Pain2D is a scalable, open-source tool that could potentially be trained for all diseases presenting with pain.

• Publisher: BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
• Subject: Analysis / Care and treatment / Chronic pain / Chronic Pain - diagnosis / Control Groups / Decision support systems / Deep learning / Diagnosis / Diagnostic support / Differential diagnosis / Genetic disorders / Guillain-Barre syndrome / Health aspects / Health care reform / Human Genetics / Humans / Information systems / Machine learning / Medical diagnosis / Medical research / Medicine / Medicine & Public Health / Muscular dystrophy / Muscular Dystrophy, Facioscapulohumeral - diagnosis / Neural networks / Neuromuscular diseases / ORPHA: 2103 / ORPHA: 269 / ORPHA: 287 / ORPHA: 606 / Pain / Patients / Pharmacology/Toxicology / Questionnaires / Rare Diseases / Respiratory distress syndrome / Software / Suffering